Tech News, Magazine & Review WordPress Theme 2017
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us
No Result
View All Result
No Result
View All Result
Home Supply Chain Updates

Coronavirus strains fragile pharmaceutical supply chain

usscmc by usscmc
March 8, 2020
Coronavirus strains fragile pharmaceutical supply chain
Share on FacebookShare on Twitter

The Indian government may hold 26 pharmaceutical ingredients and drugs made from them amid supply concerns stemming from the coronavirus, stretching an already fragile pharmaceutical supply chain.

The spread of COVID-19, which is the disease caused by the most recently discovered coronavirus that’s similar to SARS and MERS, has slowed business in China. The Indian government has preemptively restricted the exports of a range of pharmaceuticals and their ingredients, some of which are used in widely used antibiotics, to protect its domestic supply.

Much of the world’s supply of generic drugs comes from India, which relies heavily on China for their active pharmaceutical ingredients. While many health systems have yet to experience any related drug shortages and many generic drug suppliers have three to 12 months of active pharmaceutical ingredientS stocked, executives are increasingly concerned by the opaque system that is dependent on foreign countries.

“It is not a crisis yet, but it has the potential to have a significant impact,” said Scott Knoer, chief pharmacy officer at Cleveland Clinic. It is difficult to quantify with the limited data and oversight, he added.

Indian officials sent the message that they will prioritize their citizens, U.S. Pharmacopeia CEO Ron Piervincenzi said.

“That goes against the message sent by the Indian industry for years, which is that we are the medicine cabinet of the world,” he said.

No one is more reliant on China’s pharmaceutical ingredients than India, said Piervincenzi, who is working with USP employees in India and China.

“The actual shortages in India do not seem substantial. They still have enough stock to do the vast majority of their work, but they are all very worried about the supply chain,” he said. “Worry itself can lead to behavioral changes and risk.”

Several of the ingredients listed, including the antibiotics erythromycin and metronidazole as well as the antiviral drug acyclovir, are used to make sterile injectables that have endured shortages for years.

Most shortages stem from quality issues at manufacturing facilities, as well as from manufacturers that opt to make more profitable drugs. This has resulted in more than 200 current drug shortages—according to the American Society of Health-System Pharmacists’ list—that continue to jeopardize patient care and inflate healthcare costs.

Another issue is a lack of data. While drug manufacturers must relay any potential disruptions to their suppliers to the Food and Drug Administration, the same requirement does not to extend to FDA-registered active pharmaceutical ingredient facilities. This is where Sens. Susan Collins (R-Maine) and Tina Smith’s (D-Minn.) Mitigating Emergency Drug Shortages Act would help, experts said.

The bill would require active pharmaceutical ingredient manufacturers to report supply vulnerabilities, contingency plans as well as the cause, scope, impact and expected duration of shortages. It would also require studies on drug shortages’ impact on national security and encourage domestic manufacturing of pharmaceutical ingredients and finished products, among other mandates.

“The industry is allowed to keep everything secret—name of the company, place of factory, list of drugs made at that factory,” said Erin Fox, a drug shortage expert and senior director of drug information and support services at University of Utah Health.

She noted the most recent instance of a drug company preventing the FDA from stating which product was short related to COVID-19 due to “confidential commercial information.”

“This lack of transparency is irresponsible and can only lead to fear and panic,” Fox said.

Some manufacturers are diversifying their active pharmaceutical ingredient sources, which is promising, said Michael Ganio, director of pharmacy practice and quality at ASHP. Sanofi, for instance, is sourcing some of its drug ingredients from France. Others are finding sources outside of China, he said.

“We would like to see more of that to get more resiliency into the pharmaceutical supply chain,” Ganio said.

The FDA should funnel more resources to its pre-approval process so it can send more field inspectors to China to get more facilities up and running, said Marc Scheineson, an FDA lawyer at Alston & Bird and former FDA associate commissioner.

When a manufacturer submits a new drug application, the FDA conducts a pre-approval inspection to ensure the manufacturing facilities are compliant. But a pre-approval inspection backlog has held the agency back, he said.

“There’s always a huge backlog in the U.S., India and China, and pre-approval inspections really are a bottleneck,” Scheineson said. “Getting more generic suppliers are important for drug pricing as well as to reduce shortages.”

More stakeholders are offering their input, USP’s Piervincenzi said. Some pharmacy chains have asked if they should be doing their own quality testing, he said.

“It seems like this may be a tipping point,” Piervincenzi said. “Major participants in the supply chain that haven’t actively played a role in risk mitigation and quality are starting to ask questions.”

The entire supply chain have to take a more global view of quality standards, Piervincenzi added.

CivicaRx, a not-for-profit generic drug company formed by health systems, aims to divert active pharmaceutical ingredients and finished pharmaceutical sourcing from China, said Jesse Breidenbach, senior executive director of Sanford Health’s pharmacy, which is a member of CivicaRx. Similar efforts from the group purchasing and consulting organizations Premier and Vizient share that goal.

Sanford hasn’t experienced any COVID-19-related drug shortages yet, but it continues to monitor up to 70 drugs that are in short supply or vulnerable, he said. In the meantime, some of the old active pharmaceutical ingredient-manufacturing technology needs to be updated and funding should be directed to research domestic active pharmaceutical ingredient production, Breidenbach said.

“It’s scary how much of our generic-drug supply hinges on China and how limited the data is on manufacturing sourced from overseas,” he said. “All roads from generic medications seem to lead back to China, and issues like the coronavirus are not putting us in a good situation.”

Critical medicines like injectable pain medication, local anesthetics, electrolytes and antibiotics are at risk. Shortages could put patients in harm’s way and drive up costs, he said.

“It is very important for the U.S. to become less reliant on China and more self-sustaining,” Breidenbach said.

usscmc

usscmc

No Result
View All Result

Recent Posts

  • How Hapag Lloyd captured a major market share in the Container Shipping Industry in USA
  • Why USA’s East Coast is the Favorite Destination for Manufacturing Companies
  • How Trade Relations Between the USA and UK Improved After Keir Starmer Became Prime Minister
  • Tips and Tricks for Procurement Managers to Handle Their Supplier Woes
  • The Crazy Supply Chain of Walmart Spanning Across the Globe

Recent Comments

  • Top 5 Supply Chain Certifications that are in high demand | Top 5 Certifications on Top 5 Globally Recognized Supply Chain Certifications
  • 3 Best Procurement Certifications that are most valuable | Procurement Newz on Top 5 Globally Recognized Supply Chain Certifications

Archives

  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019

Categories

  • Global News
  • Supply Chain Updates

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Antispam
  • Contact Us
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms of Use

© 2025 www.usscmc.com

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us

© 2025 www.usscmc.com